KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CMRA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Comera Life Sciences Holdings, Inc. stock price on Thursday moving between $0.0215 and $0.0400
(Updated on Apr 25, 2024)

Hold candidate since Apr 25, 2024 PDF

The Comera Life Sciences Holdings, Inc. stock price fell by -11.95% on the last day (Thursday, 25th Apr 2024) from $0.0410 to $0.0361. During the last trading day the stock fluctuated 86.05% from a day low at $0.0215 to a day high of $0.0400. The price has been going up and down for this period, and there has been a -2.43% loss for the last 2 weeks. Volume has increased on the last day by 135 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 135 thousand shares were bought and sold for approximately $4.86 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.31% during the next 3 months and, with a 90% probability hold a price between $0.0276 and $0.0540 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CMRA Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Comera Life Sciences Holdings, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0403 and $0.0418. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -39.33%. Further fall is indicated until a new bottom pivot has been found. Comera Life Sciences Holdings, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Tuesday, April 16, 2024 and based on theory for this formation the price should fall by -28.81% to $0.0257 within 24 trading days since signal was issued (Friday, April 26, 2024).

Support, Risk & Stop-loss for Comera Life Sciences Holdings, Inc. stock

Comera Life Sciences Holdings, Inc. finds support from accumulated volume at $0.0360 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0185 between high and low, or 86.05%. For the last week, the stock has had daily average volatility of 17.21%.

Our recommended stop-loss: $0.0343 (-5.08%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (CMRA) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Comera Life Sciences Holdings, Inc. to open at $0.0325, and during the day (based on 14 day Average True Range), to move between $0.0304 and $0.0418, which gives a possible trading interval of +/-$0.0057 (+/-15.89%) up or down from last closing price. If Comera Life Sciences Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 31.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0360 (0.28%) than the resistance at $0.0370 (2.49%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Comera Life Sciences Holdings, Inc. stock A Buy?

Comera Life Sciences Holdings, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Comera Life Sciences Holdings, Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$0.0325 ( 9.88%) $0.0361

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CMRA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0510 41.37 %
R2 0.0440 21.79 %
R1 0.0396 9.70 %
Current price: 0.0361
Support S1 0.0255 -29.46 %
S2 0.0211 -41.55 %
S3 0.0140 -61.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0400 10.80 %
R2 0.0384 6.37 %
R1 0.0370 2.49 %
Current price 0.0361
Support S1 0.0360 -0.277%
S2 0.0350 -3.05%
S3 0.0340 -5.82%

FAQ

What is the symbol for Comera Life Sciences Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Comera Life Sciences Holdings, Inc. is CMRA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Comera Life Sciences Holdings, Inc. Stock?
Comera Life Sciences Holdings, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Comera Life Sciences Holdings, Inc. Stock?
Comera Life Sciences Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Comera Life Sciences Holdings, Inc. Stock.

What's the current price of Comera Life Sciences Holdings, Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Comera Life Sciences Holdings, Inc. (CMRA) share was $0.0361.

What is the 52-week high and low for Comera Life Sciences Holdings, Inc. Stock?
The 52-week high for Comera Life Sciences Holdings, Inc. Stock is $0.83 and the 52-week low is $0.0215.

What is the market capitalization of Comera Life Sciences Holdings, Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Comera Life Sciences Holdings, Inc. is 1.11M.
Click to get the best stock tips daily for free!

About Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings. Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis dis... CMRA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT